30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)
Description
In vitro diagnostics is a global market estimated to consist of over $120 billion. With less than half that revenue earned in the United States, an assessment of regional and country IVD markets is needed for successful business planning. Kalorama’s 30 Country IVD Market Atlas report is designed to provide you with international market detail at the country-level to help improve your forecast modeling and planning.
Whether you need Latin America, Middle East, APAC or Eastern Europe, this report has country-level markets and forecasts.
If you need geographical IVD markets by country from an authoritative source, this report also provides that. Up to date as of Q3 2023, this report is designed to cover every significant world IVD market.
One Report Covering 30 Countries
Reliable Estimates From an IVD-Focused Analyst Team (The Authors of Kalorama’s Worldwide Market for In Vitro Diagnostics)
Sizing for 19 Important IVD Market Segments
Segments Estimated for Each Country
Lab-Based and POC Segments for Many Disease Areas
Designed to Align with Other Kalorama Reports
Forecasts in Revenue to 2028 for Each Segment
CAGRS for Each Segment and Country
Updated Quarterly (4 updates annually) to Reflect Market Changes
Analyst Notes for Significant Developments
Definitions and Descriptions of Tests
Over 2800 Data Points
Over two decades of publishing in vitro diagnostic market research, Kalorama Information has heard from customers: IVD is a global industry, growth is global and our customers want more geographic coverage. As a result, we are offering geographic research and analysis focused at the country, rather than regional level in our 30 Country In Vitro Diagnostics (IVD) Market Atlas. A quarterly-updated, 30-country market research report with the major IVD segments forecasted out five years.
To replicate the 2800+ data points in the IVD Market Atlas, you’d need to buy dozens of other companies market research studies.
This quarterly updated report contains IVD markets aligned to Kalorama’s expert global estimates in our Worldwide Market for In Vitro Diagnostics, segmented for 30 important country markets and for 19 key test segments.
Countries covered in the IVD Market Atlas include:
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Egypt
France
Germany
India
Indonesia
Italy
Japan
Mexico
Netherlands
Poland
Romania
Russia
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
United States
Vietnam
Market researchers will tend to sell reports for each of these countries, rather than combine in one report. For Kalorama, our mission is different. We seek to keep companies informed with useful references when they need it, rather than publish hundreds of reports a year. The IVD Market Atlas reflects this mission.
It’s important to note that for each of these countries, there is an overall IVD market estimate and then, the most important market segments are broken out. These include:
Blood Bank Immunoassays
Blood Bank Molecular (NAT)
Clinical Chemistry
Coagulation
COVID-19
Critical Care
FOB
Glucose
Hematology
Histology/Cytology
ID/AST Microbiology
Immunoassays
Immunoassays, Micro
Molecular, Micro
Molecular, Others
Overall Country IVD
Point of Care
POC Infectious Disease
Pregnancy TestingWhile these are not every segment possible, they are the most important [most searched for/requested and largest] IVD market segments.
The report is updated every 3 months. Why? This is to keep up with market changes. It was once the case that the IVD market didn’t change rapidly. COVID-19, international changes, M&A activity, new products, point of care trends and regulatory activity have all worked together to change that. While there may not be substantial change in markets between one quarter and another, the report will catch segment changes, and you will always have an updated data set for your business planning.
Those who subscribe will be placed on our Knowledge Center product and will receive quarterly updates.